Who We Are

An independent health care consulting firm founded by Principals with many years of experience consulting and providing support for life sciences clients including pharmaceutical, biotechnology, device and diagnostic manufacturers and payers.

Our Principals and Director have extensive experience in health policy working with federal clients including the U.S. Food and Drug Administration, the Department of Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE) and the Centers for Disease Control and Prevention.

G. Caleb Alexander, MD, MS



Caleb's Bio

Jonothan C. Tierce, CPhil



Jon's Bio

Kim Heithoff, MPH, ScD


Kim's Bio

Natalie Reid, PhD, MPH, MBA



Natalie's Bio

William V. Padula, PhD



Bill's Bio

Our Team

Jeromie Ballreich


Jeromie Ballreich is an Assistant Scientist and Director of the Master of Health Sciences in Health Economics program in the Department of Health Policy and Management at Johns Hopkins Bloomberg School of Public Health. He received his Ph.D. in Health Economics from JHBSPH with a thesis in “Price Discrimination in the US Cancer Drug Market.” Previously, Dr. Ballreich received a Master in Health Economics also from JHSPH and a Bachelors in Mathematics and Economics from Lafayette College.


Francine Chingcuanco


Francine Chingcuanco's background is in epidemiology and pharmacology. Prior to joining Monument, she consulted for the Health Outcomes Research Department of Millennium Health wherein she designed and managed clinical research studies aimed at developing real-world evidence to support products in the field of personalized medicine. She holds a Masters in Health Science from Johns Hopkins Bloomberg School of Public Health as well as an Honours Bachelor of Science from the University of Toronto.


Elisabeth H. Hazard



Dr. Hazard has over twenty years of experience working as a health care consultant. She was a founding leader of Value Medics Research, Inc. Her specialty is value development and value communications. She was an early pioneer in creating value development plans for medical technologies and facilitated the understanding of how demonstrations of economic value could be used effectively by product development and marketing teams. Dr. Hazard has worked with major pharmaceutical companies in the US and Europe and on dozens of medical technologies.

Shreena Malaviya



Shreena Malaviya specializes in health economics and modeling. Her background is in pharmacology and management. Previously, she worked as consultant internationally on projects such as building capacity in health economics, and analyzing the effectiveness and efficiency of health systems. She has also worked in reimbursement and risk management for specialty drug products. She holds a Masters in Health from Johns Hopkins Bloomberg school of Public Health and a Bachelor of Science from McGill University.



Omar Mansour



Omar Mansour specializes in the application of pharmacoepidemiology methods. Prior to joining Monument, he was a scholar at the Bloomberg School's Center for Drug Safety and Effectiveness where he designed and conducted comparative effectiveness studies on various topics using electronic medical records, commercial insurance claims, and large national surveys. He holds a Masters in Health Science from JHSPH and a Bachelor of Arts in biology with a minor in statistics from Macalester College.



Carter McCormick



Carter McCormick specializes in pharmacoepidemiology and pharmacoeconomics. He is a PhD candidate in the Department of Pharmacy Systems, Outcomes, and Policy at the University of Illinois at Chicago where he evaluates the impact of policies from the city to federal level using insurance claims and prescription dispensing data. He holds a Masters of Public Health in global health and a certificate in human rights from Emory University Rollins School of Public Health, and a Bachelor of Arts in public policy and exercise and sport science from the University of North Carolina at Chapel Hill.

Divya Mohan



Divya Mohan’s background is in health economics and biomedical engineering. She specializes in patient preferences and cost-effectiveness analysis. Previously she worked at the Economist Intelligence Unit on projects including concept testing, communications strategy, market sizing, as well as customer perception and insight studies for imaging systems, in-vitro diagnostics, surgical devices and procedures. She holds a Masters in Health Science from JHSPH and a Bachelor of Engineering from Nanyang Technological University.


Katharine Ozenberger



Katharine Ozenberger specializes in epidemiology and pharmacoepidemiology. She is a PhD candidate in the Department of Pharmacy Systems, Outcomes, and Policy at the University of Illinois at Chicago where she designs and conducts research using longitudinal data from population-based cohorts, prescription dispensing, and commercial insurance claims. She holds a Masters in Science in epidemiology from the UIC School of Public Health and a Bachelor of Science in biology from the University of Colorado Denver.



Daniel Touchette


Daniel Touchette is Professor and Director of Graduate Studies for the Masters in Comparative Effectiveness Research program at the University of Illinois at Chicago (UIC) College of Pharmacy. His primary research interests are evaluating the cost-effectiveness of pharmaceutical agents assessing the effectiveness and cost-effectiveness of clinical pharmacist and other health practitioner services, and developing and assessing methods for improving adherence to medication regimens. Dr. Touchette has obtained grant funding from AHRQ, NIH, and numerous foundations and other sources. Most recently, he has developed decision models for the Institute for Clinical and Economic Review (ICER) and leads UIC’s involvement in ICERs Health Economic Network. He has authored over 70 peer-reviewed manuscripts and reports.

Danyang Wang


Danyang Wang is a consultant who specializes in economic modeling and cost-effectiveness analysis. Before joining Monument Analytics she developed probabilistic Markov models to assess the cost-effectiveness of community health interventions while in training at Johns Hopkins Bloomberg School of Public Health. She holds a Master of Health Science from Johns Hopkins and a Bachelor of Science in Biology with a minor in Economics from Emory University.


How About You?


We are always on the lookout for top talent. If you have rigorous training, great interpersonal skills and a passion for bringing innovative health care solutions to market, CONTACT US. We want to know more about you.